The pharmaceutical company at the center of the EpiPen price-gouging controversy has decided to lower the cost of its medication for some patients.

Mylan, which had hiked the price of the medication by more than 400 percent, announced plans to cover up to $300 — or roughly 50 percent — of the cost of a pack of two EpiPens for patients who were paying the full amount.

Recommended Stories

Earnest: Obama doesn’t regret expanding EpiPens

Are negotiators ‘fighting to lower drug prices’ actually making them higher?

FDA approves first generic competitor for EpiPen